Nagaoka H - Search Results

1

Effects of Lentinus edodes mycelia on dietary-induced atherosclerotic involvement in rabbit aorta.

Yamada T, Oinuma T, Niihashi M, Mitsumata M, Fujioka T, Hasegawa K, Nagaoka H, Itakura H. Yamada T, et al. Among authors: nagaoka h. J Atheroscler Thromb. 2002;9(3):149-56. doi: 10.5551/jat.9.149. J Atheroscler Thromb. 2002. PMID: 12226557 Free article.

2

Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.

Yamada T, Tomioka K, Horie M, Sakurai Y, Nagaoka H, Mase T. Yamada T, et al. Among authors: nagaoka h. Biochem Biophys Res Commun. 1991 Apr 30;176(2):781-5. doi: 10.1016/s0006-291x(05)80253-0. Biochem Biophys Res Commun. 1991. PMID: 2025290

3

Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.

Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K. Yamada T, et al. Among authors: nagaoka h. Lipids. 1991 Dec;26(12):1179-83. doi: 10.1007/BF02536527. Lipids. 1991. PMID: 1668114

4

Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.

Yamada T, Tomioka K, Saito M, Horie M, Mase T, Hara H, Nagaoka H. Yamada T, et al. Among authors: nagaoka h. Arch Int Pharmacodyn Ther. 1990 Nov-Dec;308:123-36. Arch Int Pharmacodyn Ther. 1990. PMID: 2099131

5

2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).

Nagaoka H, Hara H, Suzuki T, Takahashi T, Takeuchi M, Matsuhisa A, Saito M, Yamada T, Tomioka K, Mase T. Nagaoka H, et al. Chem Pharm Bull (Tokyo). 1997 Oct;45(10):1659-64. doi: 10.1248/cpb.45.1659. Chem Pharm Bull (Tokyo). 1997. PMID: 9353894

6

2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists.

Suzuki T, Nagaoka H, Hara H, Takeuchi M, Saito M, Yamada T, Tomioka K, Matsumoto H, Takanuki K, Mase T. Suzuki T, et al. Among authors: nagaoka h. Chem Pharm Bull (Tokyo). 1999 Feb;47(2):165-70. doi: 10.1248/cpb.47.165. Chem Pharm Bull (Tokyo). 1999. PMID: 10071851

7

2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists.

Suzuki T, Nagaoka H, Kondo Y, Takahashi T, Takeuchi M, Hara H, Saito M, Yamada T, Tomioka K, Hamada M, Mase T. Suzuki T, et al. Among authors: nagaoka h. Chem Pharm Bull (Tokyo). 1998 Sep;46(9):1468-73. doi: 10.1248/cpb.46.1468. Chem Pharm Bull (Tokyo). 1998. PMID: 9775441

8

Determination of 2',3'-dideoxyinosine and 2',3'-dideoxyadenosine in rat plasma by high-performance liquid chromatography with precolumn fluorescence derivatization.

Nagaoka H, Nohta H, Saito M, Ohkura Y. Nagaoka H, et al. Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2202-4. doi: 10.1248/cpb.40.2202. Chem Pharm Bull (Tokyo). 1992. PMID: 1423782

9

Precolumn derivatization of nucleotides based on fluorescent carbamate formation of the sugar moieties in high-performance liquid chromatography.

Nagaoka H, Nohta H, Saito M, Ohkura Y. Nagaoka H, et al. Chem Pharm Bull (Tokyo). 1992 Sep;40(9):2559-61. doi: 10.1248/cpb.40.2559. Chem Pharm Bull (Tokyo). 1992. PMID: 1446378

10

A fluorescent DNA probe prepared by the direct derivatization of the sugar moiety for hybridization assay.

Nagaoka H, Nohta H, Saito M, Ohkura Y. Nagaoka H, et al. Chem Pharm Bull (Tokyo). 1992 Oct;40(10):2852-3. doi: 10.1248/cpb.40.2852. Chem Pharm Bull (Tokyo). 1992. PMID: 1464117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters